LoRusso, P. M., Li, J., Burger, A., Heilbrun, L. K., Sausville, E. A., Boerner, S. A., . . . Shapiro, G. I. (2016). Phase I safety, pharmacokinetic and pharmacodynamic study of the poly (ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) in combination with irinotecan in patients with advanced solid tumors. Clin Cancer Res.
Chicago-tyylinen lähdeviittausLoRusso, Patricia M., et al. "Phase I Safety, Pharmacokinetic and Pharmacodynamic Study of the Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888) in Combination With Irinotecan in Patients With Advanced Solid Tumors." Clin Cancer Res 2016.
MLA-viiteLoRusso, Patricia M., et al. "Phase I Safety, Pharmacokinetic and Pharmacodynamic Study of the Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888) in Combination With Irinotecan in Patients With Advanced Solid Tumors." Clin Cancer Res 2016.